STOCKHOLM, Sweden--(BUSINESS WIRE)--Assoc. Prof. Börje Darpö has today been appointed Vice President, Pharmaceutical Development with responsibility for the company’s clinical development projects. He will be a member of the Medivir (STO:MVIRB) management group.
